A new verification link is sent. Check email. Resend confirmation email
EYLEA (English Alternative)
$1,599.00
| Quantity | Discount (%) | Price |
|---|---|---|
| 1 - 5 | — | $1,599.00 |
| 6 - 10 | 6.25 % | $1,499.00 |
| 11 - 20 | 6.88 % | $1,489.00 |
| 21+ | 7.5 % | $1,479.00 |
EYLEA® (aflibercept) is a prescription-only, intravitreal injectable medication designed for the treatment of various retinal vascular diseases. It is a recombinant fusion protein that acts as a VEGF inhibitor, targeting vascular endothelial growth factor-A (VEGF-A), VEGF-B, and placental growth factor (PlGF) to reduce abnormal blood vessel growth and fluid leakage in the eye. EYLEA® is indicated for conditions such as wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy (DR), and retinopathy of prematurity (ROP). It is administered via intravitreal injection by a trained ophthalmologist.



